Biomarker for hypertension-preeclampsia: are we close yet?
Open Access
- 31 July 2007
- journal article
- editorial
- Published by Elsevier BV in American Journal of Obstetrics and Gynecology
- Vol. 197 (1), 1-2
- https://doi.org/10.1016/j.ajog.2007.04.021
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Soluble Endoglin and Other Circulating Antiangiogenic Factors in PreeclampsiaNew England Journal of Medicine, 2006
- Circulating angiogenic factors in preeclampsia, gestational proteinuria, and preeclampsia superimposed on chronic glomerulonephritisAmerican Journal of Obstetrics and Gynecology, 2006
- Soluble endoglin, a novel circulating anti-angiogenic factor in preeclampsia (PE)American Journal of Obstetrics and Gynecology, 2005
- Diagnosis, Prevention, and Management of EclampsiaObstetrics & Gynecology, 2005
- Pre-eclampsiaThe Lancet, 2005
- Diagnosis, Controversies, and Management of the Syndrome of Hemolysis, Elevated Liver Enzymes, and Low Platelet CountObstetrics & Gynecology, 2004
- Circulating Angiogenic Factors and the Risk of PreeclampsiaNew England Journal of Medicine, 2004
- Mild gestational hypertension remote from term: Progression and outcomeAmerican Journal of Obstetrics and Gynecology, 2001
- Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in PregnancyAmerican Journal of Obstetrics and Gynecology, 2000
- The detection, investigation and management of hypertension in pregnancy: full consensus statementAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2000